Regulatory document
2022.01.13_Final GSR 14(E)_To amend rule 2 to substitute cell or stem cell derived product…
CDSCO · Regulations · India
Key facts
| Title | 2022.01.13_Final GSR 14(E)_To amend rule 2 to substitute cell or stem cell derived product under NDCTR 2019 |
|---|---|
| Issuer | Central Drugs Standard Control Organization |
| Source | CDSCO |
| Document type | Regulations |
| Country or region | India |
| Document | cdsco.gov.in |
| Issuer website | cdsco.gov.in |
At a glance
- Yes Full text searchable in Orca1
- 1,000+ Documents from this issuer in Orca1
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Global regulations and guidance
Regulations, guidance and official notices from medical device and medicines regulators worldwide, collected by Orca1 from each issuer's website. Only the title, issuer, date and link are shown here; the full text is searchable in Orca1.